Pancreatic Cancer Research

ResearcherFirst Hospital of Jilin UniversityActive in the last 2 years

Tongjia Chu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5065915447. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 2 papers · 2026: 2 papers

Papers 4

  1. Arachidonic acid induces pyroptosis via a non-autophagic function of mitophagy and enhances immunotherapy in a PDAC model. Co-author DOI 10.1038/s41467-025-68267-2↗
  2. CAV1-DOT1L axis in TAM-derived EVs orchestrates VM and sensitises PDAC to combined VM and VEGF targeting. Co-author DOI 10.1136/gutjnl-2025-337293↗
  3. CircERC1 facilitates chemoresistance through inhibiting pyroptosis and remodeling extracellular matrix in pancreatic cancer. Co-author DOI 10.1186/s12943-025-02385-9↗
  4. Hsa_circ_0058495-mediated IGF2BP2 ubiquitination and m6A modification of MEKK1 promote the progression of PDAC. Co-author DOI 10.7150/thno.117202↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Wei · 4 shared papers, 2025–2026 · strength 1.00
  2. Shengnan Lv · 3 shared papers, 2025–2026 · strength 0.68
  3. Ziyu Liu · 1 shared paper, 2026 · strength 0.32
  4. Jian Zhang · 1 shared paper, 2025 · strength 0.24
  5. Jian Zhang · 1 shared paper, 2025 · strength 0.22
  6. Xinyu Peng · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.